ID

18913

Beskrivning

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00060086

Länk

https://clinicaltrials.gov/show/NCT00060086

Nyckelord

Versioner (1)
  1. 2016-11-24 2016-11-24 -
Uppladdad den

24 november 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Prostate Cancer NCT00060086

Engelsk

Eligibility Prostate Cancer NCT00060086

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically confirmed adenocarcinoma of the prostate
Beskrivning

Adenocarcinoma of prostate

Datatyp

boolean

Alias
UMLS CUI [1]
C0007112
must have undergone prior surgery or radiotherapy for the primary tumor
Beskrivning

Prior surgery primary tumor | prior radiation therapy primary tumor

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0455610
UMLS CUI [1,2]
C0677930
UMLS CUI [2,1]
C0279134
UMLS CUI [2,2]
C0677930
documented rising prostate-specific antigen (psa) level, defined by the following criteria:
Beskrivning

Raised prostate specific antigen

Datatyp

boolean

Alias
UMLS CUI [1]
C0178415
absolute level of psa at least 0.2 ng/ml but less than 5.0 ng/ml
Beskrivning

Prostate specific antigen measurement Absolute

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0201544
UMLS CUI [1,2]
C0205344
rising psa level must be confirmed at least 1 week later
Beskrivning

Raised prostate specific antigen Confirmation Point in time

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0178415
UMLS CUI [1,2]
C0750484
UMLS CUI [1,3]
C1442880
adequate psa time points to calculate a psa doubling time
Beskrivning

Prostate-Specific Antigen measurement Point in time Quantity | Calculation Prostate-Specific Antigen Doubling Time

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0201544
UMLS CUI [1,2]
C1442880
UMLS CUI [1,3]
C1265611
UMLS CUI [2,1]
C1441506
UMLS CUI [2,2]
C0138741
UMLS CUI [2,3]
C1705764
UMLS CUI [2,4]
C0040223
gleason score no greater than 7
Beskrivning

Gleason score

Datatyp

boolean

Alias
UMLS CUI [1]
C3203027
age 18 and over
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
performance status ecog 0-1
Beskrivning

ECOG performance status

Datatyp

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy at least 6 months
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
no other malignancy within the past 5 years except nonmelanoma skin cancer
Beskrivning

Malignant Neoplasms | Skin carcinoma

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
no other serious concurrent systemic medical disorders that would preclude study compliance
Beskrivning

Systemic disease Serious Excludes Protocol Compliance

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C0332196
UMLS CUI [1,4]
C0525058
no known allergy to pomegranate juice
Beskrivning

Hypersensitivity POMEGRANATE JUICE

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1327962
more than 4 weeks since prior participation in another experimental study
Beskrivning

Study Subject Participation Status Previous

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C0205156
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
nodal involvement
Beskrivning

nodal involvement

Datatyp

boolean

Alias
UMLS CUI [1]
C0441949
evidence of metastatic disease
Beskrivning

Neoplasm Metastasis Evidence of

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0332120
prior hormonal therapy
Beskrivning

Prior Hormone Therapy

Datatyp

boolean

Alias
UMLS CUI [1]
C1514460
concurrent hormonal therapy for rising psa levels after initial therapy for prostate cancer
Beskrivning

Therapeutic procedure Initial Prostate carcinoma | Hormone Therapy Raised prostate specific antigen

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0205265
UMLS CUI [1,3]
C0600139
UMLS CUI [2,1]
C0279025
UMLS CUI [2,2]
C0178415
concurrent participation in another experimental study
Beskrivning

Study Subject Participation Status

Datatyp

boolean

Alias
UMLS CUI [1]
C2348568
other concurrent systemic or local therapy for prostate cancer
Beskrivning

systemic therapy Prostate carcinoma | Local Therapy Prostate carcinoma

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1515119
UMLS CUI [1,2]
C0600139
UMLS CUI [2,1]
C1517925
UMLS CUI [2,2]
C0600139
initiation or discontinuation of any new nutritional or dietary supplements during study participation
Beskrivning

Initiation Nutritional Supplements New | Discontinuation Nutritional Supplements New

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1704686
UMLS CUI [1,2]
C0242295
UMLS CUI [1,3]
C0205314
UMLS CUI [2,1]
C0457454
UMLS CUI [2,2]
C0242295
UMLS CUI [2,3]
C0205314
Tillbaka till toppen

Similar models

Eligibility Prostate Cancer NCT00060086

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate
Item
histologically confirmed adenocarcinoma of the prostate
boolean
C0007112 (UMLS CUI [1])
Prior surgery primary tumor | prior radiation therapy primary tumor
Item
must have undergone prior surgery or radiotherapy for the primary tumor
boolean
C0455610 (UMLS CUI [1,1])
C0677930 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2,1])
C0677930 (UMLS CUI [2,2])
Raised prostate specific antigen
Item
documented rising prostate-specific antigen (psa) level, defined by the following criteria:
boolean
C0178415 (UMLS CUI [1])
Prostate specific antigen measurement Absolute
Item
absolute level of psa at least 0.2 ng/ml but less than 5.0 ng/ml
boolean
C0201544 (UMLS CUI [1,1])
C0205344 (UMLS CUI [1,2])
Raised prostate specific antigen Confirmation Point in time
Item
rising psa level must be confirmed at least 1 week later
boolean
C0178415 (UMLS CUI [1,1])
C0750484 (UMLS CUI [1,2])
C1442880 (UMLS CUI [1,3])
Prostate-Specific Antigen measurement Point in time Quantity | Calculation Prostate-Specific Antigen Doubling Time
Item
adequate psa time points to calculate a psa doubling time
boolean
C0201544 (UMLS CUI [1,1])
C1442880 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C1441506 (UMLS CUI [2,1])
C0138741 (UMLS CUI [2,2])
C1705764 (UMLS CUI [2,3])
C0040223 (UMLS CUI [2,4])
Gleason score
Item
gleason score no greater than 7
boolean
C3203027 (UMLS CUI [1])
Age
Item
age 18 and over
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
performance status ecog 0-1
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy at least 6 months
boolean
C0023671 (UMLS CUI [1])
Malignant Neoplasms | Skin carcinoma
Item
no other malignancy within the past 5 years except nonmelanoma skin cancer
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
Systemic disease Serious Excludes Protocol Compliance
Item
no other serious concurrent systemic medical disorders that would preclude study compliance
boolean
C0442893 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C0332196 (UMLS CUI [1,3])
C0525058 (UMLS CUI [1,4])
Hypersensitivity POMEGRANATE JUICE
Item
no known allergy to pomegranate juice
boolean
C0020517 (UMLS CUI [1,1])
C1327962 (UMLS CUI [1,2])
Study Subject Participation Status Previous
Item
more than 4 weeks since prior participation in another experimental study
boolean
C2348568 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
nodal involvement
Item
nodal involvement
boolean
C0441949 (UMLS CUI [1])
Neoplasm Metastasis Evidence of
Item
evidence of metastatic disease
boolean
C0027627 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
Prior Hormone Therapy
Item
prior hormonal therapy
boolean
C1514460 (UMLS CUI [1])
Therapeutic procedure Initial Prostate carcinoma | Hormone Therapy Raised prostate specific antigen
Item
concurrent hormonal therapy for rising psa levels after initial therapy for prostate cancer
boolean
C0087111 (UMLS CUI [1,1])
C0205265 (UMLS CUI [1,2])
C0600139 (UMLS CUI [1,3])
C0279025 (UMLS CUI [2,1])
C0178415 (UMLS CUI [2,2])
Study Subject Participation Status
Item
concurrent participation in another experimental study
boolean
C2348568 (UMLS CUI [1])
systemic therapy Prostate carcinoma | Local Therapy Prostate carcinoma
Item
other concurrent systemic or local therapy for prostate cancer
boolean
C1515119 (UMLS CUI [1,1])
C0600139 (UMLS CUI [1,2])
C1517925 (UMLS CUI [2,1])
C0600139 (UMLS CUI [2,2])
Initiation Nutritional Supplements New | Discontinuation Nutritional Supplements New
Item
initiation or discontinuation of any new nutritional or dietary supplements during study participation
boolean
C1704686 (UMLS CUI [1,1])
C0242295 (UMLS CUI [1,2])
C0205314 (UMLS CUI [1,3])
C0457454 (UMLS CUI [2,1])
C0242295 (UMLS CUI [2,2])
C0205314 (UMLS CUI [2,3])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial